This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 17126 results found since Jan 2013.

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Condition:   Alopecia Areata Interventions:   Drug: Upadacitinib;   Drug: Placebo Sponsor:   AbbVie Not yet recruiting
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Prevention of Alopecia in Patients With Localised Breast Cancer
Condition:   Chemotherapy-induced Alopecia Interventions:   Other: standard cold cap;   Other: scalp-cooling technique Sponsor:   Centre Francois Baclesse Recruiting
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
Acta Derm Venereol. 2023 Aug 25;103:adv12445. doi: 10.2340/actadv.v103.12445.ABSTRACTAlopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the subtypes alopecia totalis and alopecia universalis, in the first year after diagnosis of an episode of alopecia areata. Approximately 5% of all patients (adults (age ≥ 18 years), n = 7,703; adolescents (age 12-17 years), n = 595) had alopecia totalis or alopecia universalis. Corticosteroids w...
Source: Acta Derm Venereol A... - August 25, 2023 Category: Dermatology Authors: Nicolae Done Lauren Bartolome Elyse Swallow Wei Gao Christopher Carley Travis Wang Arash Mostaghimi Source Type: research

Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal
AbstractDespite its efficacy for treating androgenetic alopecia, finasteride, an inhibitor of 5 α-reductase (i.e., the enzyme converting testosterone, T, into dihydrotestosterone, DHT), is associated with several side effects including sexual dysfunction (e.g., erectile dysfunction). These side effects may persist after drug suspension, inducing the so-called post-finasteride syndrome (PFS). The effects of subchronic treatment with finasteride (i.e., 20 days) and its withdrawal (i.e., 1 month) in rat corpus cavernosum have been explored here. Data obtained show that the treatment was able to decrease the levels of the enz...
Source: Andrology - August 25, 2023 Category: Urology & Nephrology Authors: Silvia Diviccaro, Monika Herian, Lucia Cioffi, Matteo Audano, Nico Mitro, Donatella Caruso, Silvia Giatti, Roberto Cosimo Melcangi Tags: SHORT COMMUNICATION Source Type: research